Table of Content

1 Study Coverage
1.1 Gene Therapy in CNS Disorder Product Introduction
1.2 Global Gene Therapy in CNS Disorder Outlook 2018 VS 2024 VS 2034
1.2.1 Global Gene Therapy in CNS Disorder Market Size for the Year 2018-2034
1.2.2 India Gene Therapy in CNS Disorder Market Size for the Year 2018-2034
1.3 Gene Therapy in CNS Disorder Market Size, India VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of India Gene Therapy in CNS Disorder in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of Gene Therapy in CNS Disorder Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4 Gene Therapy in CNS Disorder Market Dynamics
1.4.1 Gene Therapy in CNS Disorder Industry Trends
1.4.2 Gene Therapy in CNS Disorder Market Drivers
1.4.3 Gene Therapy in CNS Disorder Market Challenges
1.4.4 Gene Therapy in CNS Disorder Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Gene Therapy in CNS Disorder by Type
2.1 Gene Therapy in CNS Disorder Market Segment by Type
2.1.1 Viral Gene Therapy
2.1.2 Non-viral Gene Therapy
2.2 Global Gene Therapy in CNS Disorder Market Size by Type (2018, 2024 & 2034)
2.3 Global Gene Therapy in CNS Disorder Market Size by Type (2018-2034)
2.4 India Gene Therapy in CNS Disorder Market Size by Type (2018, 2024 & 2034)
2.5 India Gene Therapy in CNS Disorder Market Size by Type (2018-2034)
3 Gene Therapy in CNS Disorder by Application
3.1 Gene Therapy in CNS Disorder Market Segment by Application
3.1.1 Alzheimer's Disease
3.1.2 Huntington's Disease
3.1.3 Parkinson's Disease
3.1.4 Batten Disease
3.2 Global Gene Therapy in CNS Disorder Market Size by Application (2018, 2024 & 2034)
3.3 Global Gene Therapy in CNS Disorder Market Size by Application (2018-2034)
3.4 India Gene Therapy in CNS Disorder Market Size by Application (2018, 2024 & 2034)
3.5 India Gene Therapy in CNS Disorder Market Size by Application (2018-2034)
4 Global Gene Therapy in CNS Disorder Competitor Landscape by Company
4.1 Global Gene Therapy in CNS Disorder Market Size by Company
4.1.1 Global Key Companies of Gene Therapy in CNS Disorder, Ranked by Revenue (2024)
4.1.2 Global Gene Therapy in CNS Disorder Revenue by Player (2018-2023)
4.2 Global Gene Therapy in CNS Disorder Concentration Ratio (CR)
4.2.1 Gene Therapy in CNS Disorder Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Gene Therapy in CNS Disorder in 2024
4.2.3 Global Gene Therapy in CNS Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Gene Therapy in CNS Disorder Head office and Area Served
4.4 Global Key Players of Gene Therapy in CNS Disorder, Product and Application
4.5 Global Key Players of Gene Therapy in CNS Disorder, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Gene Therapy in CNS Disorder Market Size by Company
4.7.1 Key Players of Gene Therapy in CNS Disorder in India, Ranked by Revenue (2024)
4.7.2 India Gene Therapy in CNS Disorder Revenue by Players (2021, 2024 & 2023)
5 Global Gene Therapy in CNS Disorder Market Size by Region
5.1 Global Gene Therapy in CNS Disorder Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Gene Therapy in CNS Disorder Market Size by Region (2018-2034)
5.2.1 Global Gene Therapy in CNS Disorder Market Size by Region: 2018-2023
5.2.2 Global Gene Therapy in CNS Disorder Market Size by Region (2024-2034)
6 Americas
6.1 Americas Gene Therapy in CNS Disorder Market Size YoY Growth 2018-2034
6.2 Americas Gene Therapy in CNS Disorder Market Size by Type
6.2.1 Americas Gene Therapy in CNS Disorder Market Size by Type (2018-2023)
6.2.2 Americas Gene Therapy in CNS Disorder Market Size by Type (2024-2034)
6.2.3 Americas Gene Therapy in CNS Disorder Market Share by Type (2018-2034)
6.3 Americas Gene Therapy in CNS Disorder Market Size by Application
6.3.1 Americas Gene Therapy in CNS Disorder Market Size by Application (2018-2023)
6.3.2 Americas Gene Therapy in CNS Disorder Market Size by Application (2024-2034)
6.3.3 Americas Gene Therapy in CNS Disorder Market Share by Application (2018-2034)
6.4 Americas Gene Therapy in CNS Disorder Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Gene Therapy in CNS Disorder Market Size YoY Growth 2018-2034
7.2 EMEA Gene Therapy in CNS Disorder Market Size by Type
7.2.1 EMEA Gene Therapy in CNS Disorder Market Size by Type (2018-2023)
7.2.2 EMEA Gene Therapy in CNS Disorder Market Size by Type (2024-2034)
7.2.3 EMEA Gene Therapy in CNS Disorder Market Share by Type (2018-2034)
7.3 EMEA Gene Therapy in CNS Disorder Market Size by Application
7.3.1 EMEA Gene Therapy in CNS Disorder Market Size by Application (2018-2023)
7.3.2 EMEA Gene Therapy in CNS Disorder Market Size by Application (2024-2034)
7.3.3 EMEA Gene Therapy in CNS Disorder Market Share by Application (2018-2034)
7.4 EMEA Gene Therapy in CNS Disorder Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Gene Therapy in CNS Disorder Market Size YoY Growth 2018-2034
8.2 China Gene Therapy in CNS Disorder Market Size by Type
8.2.1 China Gene Therapy in CNS Disorder Market Size by Type (2018-2023)
8.2.2 China Gene Therapy in CNS Disorder Market Size by Type (2024-2034)
8.2.3 China Gene Therapy in CNS Disorder Market Share by Type (2018-2034)
8.3 China Gene Therapy in CNS Disorder Market Size by Application
8.3.1 China Gene Therapy in CNS Disorder Market Size by Application (2018-2023)
8.3.2 China Gene Therapy in CNS Disorder Market Size by Application (2024-2034)
8.3.3 China Gene Therapy in CNS Disorder Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Gene Therapy in CNS Disorder Market Size YoY Growth 2018-2034
9.2 APAC Gene Therapy in CNS Disorder Market Size by Type
9.2.1 APAC Gene Therapy in CNS Disorder Market Size by Type (2018-2023)
9.2.2 APAC Gene Therapy in CNS Disorder Market Size by Type (2024-2034)
9.2.3 APAC Gene Therapy in CNS Disorder Market Share by Type (2018-2034)
9.3 APAC Gene Therapy in CNS Disorder Market Size by Application
9.3.1 APAC Gene Therapy in CNS Disorder Market Size by Application (2018-2023)
9.3.2 APAC Gene Therapy in CNS Disorder Market Size by Application (2024-2034)
9.3.3 APAC Gene Therapy in CNS Disorder Market Share by Application (2018-2034)
9.4 APAC Gene Therapy in CNS Disorder Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Voyager Therapeutics
10.1.1 Voyager Therapeutics Company Details
10.1.2 Voyager Therapeutics Business Overview
10.1.3 Voyager Therapeutics Gene Therapy in CNS Disorder Introduction
10.1.4 Voyager Therapeutics Revenue in Gene Therapy in CNS Disorder Business (2018-2023)
10.1.5 Voyager Therapeutics Recent Development
10.2 Spark Therapeutics
10.2.1 Spark Therapeutics Company Details
10.2.2 Spark Therapeutics Business Overview
10.2.3 Spark Therapeutics Gene Therapy in CNS Disorder Introduction
10.2.4 Spark Therapeutics Revenue in Gene Therapy in CNS Disorder Business (2018-2023)
10.2.5 Spark Therapeutics Recent Development
10.3 Novartis AG
10.3.1 Novartis AG Company Details
10.3.2 Novartis AG Business Overview
10.3.3 Novartis AG Gene Therapy in CNS Disorder Introduction
10.3.4 Novartis AG Revenue in Gene Therapy in CNS Disorder Business (2018-2023)
10.3.5 Novartis AG Recent Development
10.4 Bluebird Bio Inc.
10.4.1 Bluebird Bio Inc. Company Details
10.4.2 Bluebird Bio Inc. Business Overview
10.4.3 Bluebird Bio Inc. Gene Therapy in CNS Disorder Introduction
10.4.4 Bluebird Bio Inc. Revenue in Gene Therapy in CNS Disorder Business (2018-2023)
10.4.5 Bluebird Bio Inc. Recent Development
10.5 Biogen
10.5.1 Biogen Company Details
10.5.2 Biogen Business Overview
10.5.3 Biogen Gene Therapy in CNS Disorder Introduction
10.5.4 Biogen Revenue in Gene Therapy in CNS Disorder Business (2018-2023)
10.5.5 Biogen Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Gene Therapy in CNS Disorder Market Size India VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. Gene Therapy in CNS Disorder Market Trends
Table 3. Gene Therapy in CNS Disorder Market Drivers
Table 4. Gene Therapy in CNS Disorder Market Challenges
Table 5. Gene Therapy in CNS Disorder Market Restraints
Table 6. Global Gene Therapy in CNS Disorder Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Gene Therapy in CNS Disorder Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Gene Therapy in CNS Disorder Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Gene Therapy in CNS Disorder Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of Gene Therapy in CNS Disorder, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Gene Therapy in CNS Disorder Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Gene Therapy in CNS Disorder Revenue Share by Player, 2018-2023
Table 13. Global Gene Therapy in CNS Disorder Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gene Therapy in CNS Disorder by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in CNS Disorder as of 2024)
Table 15. Global Key Players of Gene Therapy in CNS Disorder, Headquarters and Area Served
Table 16. Global Key Players of Gene Therapy in CNS Disorder, Product and Application
Table 17. Global Key Players of Gene Therapy in CNS Disorder, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Gene Therapy in CNS Disorder in India, Ranked by Revenue (2024) & (US$ Million)
Table 20. India Gene Therapy in CNS Disorder Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. India Gene Therapy in CNS Disorder Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global Gene Therapy in CNS Disorder Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global Gene Therapy in CNS Disorder Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Gene Therapy in CNS Disorder Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas Gene Therapy in CNS Disorder Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Gene Therapy in CNS Disorder Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas Gene Therapy in CNS Disorder Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Gene Therapy in CNS Disorder Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas Gene Therapy in CNS Disorder Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas Gene Therapy in CNS Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Gene Therapy in CNS Disorder Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA Gene Therapy in CNS Disorder Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Gene Therapy in CNS Disorder Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA Gene Therapy in CNS Disorder Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Gene Therapy in CNS Disorder Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA Gene Therapy in CNS Disorder Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA Gene Therapy in CNS Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Gene Therapy in CNS Disorder Market Size by Country (2024-2034) & (US$ Million)
Table 39. China Gene Therapy in CNS Disorder Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Gene Therapy in CNS Disorder Market Size by Type (2024-2034) & (US$ Million)
Table 41. China Gene Therapy in CNS Disorder Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Gene Therapy in CNS Disorder Market Size by Application (2024-2034) & (US$ Million)
Table 43. China Gene Therapy in CNS Disorder Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC Gene Therapy in CNS Disorder Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Gene Therapy in CNS Disorder Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC Gene Therapy in CNS Disorder Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Gene Therapy in CNS Disorder Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC Gene Therapy in CNS Disorder Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC Gene Therapy in CNS Disorder Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Gene Therapy in CNS Disorder Market Size by Region (2024-2034) & (US$ Million)
Table 51. Voyager Therapeutics Company Details
Table 52. Voyager Therapeutics Business Overview
Table 53. Voyager Therapeutics Gene Therapy in CNS Disorder Product
Table 54. Voyager Therapeutics Revenue in Gene Therapy in CNS Disorder Business (2018-2023) & (US$ Million)
Table 55. Voyager Therapeutics Recent Development
Table 56. Spark Therapeutics Company Details
Table 57. Spark Therapeutics Business Overview
Table 58. Spark Therapeutics Gene Therapy in CNS Disorder Product
Table 59. Spark Therapeutics Revenue in Gene Therapy in CNS Disorder Business (2018-2023) & (US$ Million)
Table 60. Spark Therapeutics Recent Development
Table 61. Novartis AG Company Details
Table 62. Novartis AG Business Overview
Table 63. Novartis AG Gene Therapy in CNS Disorder Product
Table 64. Novartis AG Revenue in Gene Therapy in CNS Disorder Business (2018-2023) & (US$ Million)
Table 65. Novartis AG Recent Development
Table 66. Bluebird Bio Inc. Company Details
Table 67. Bluebird Bio Inc. Business Overview
Table 68. Bluebird Bio Inc. Gene Therapy in CNS Disorder Product
Table 69. Bluebird Bio Inc. Revenue in Gene Therapy in CNS Disorder Business (2018-2023) & (US$ Million)
Table 70. Bluebird Bio Inc. Recent Development
Table 71. Biogen Company Details
Table 72. Biogen Business Overview
Table 73. Biogen Gene Therapy in CNS Disorder Product
Table 74. Biogen Revenue in Gene Therapy in CNS Disorder Business (2018-2023) & (US$ Million)
Table 75. Biogen Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Therapy in CNS Disorder Product Picture
Figure 2. Global Gene Therapy in CNS Disorder Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Gene Therapy in CNS Disorder Market Size 2018-2034 (US$ Million)
Figure 4. India Gene Therapy in CNS Disorder Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. India Gene Therapy in CNS Disorder Market Size 2018-2034 (US$ Million)
Figure 6. India Gene Therapy in CNS Disorder Market Share in Global 2018-2034
Figure 7. Gene Therapy in CNS Disorder Report Years Considered
Figure 8. Product Picture of Viral Gene Therapy
Figure 9. Product Picture of Non-viral Gene Therapy
Figure 10. Global Gene Therapy in CNS Disorder Market Share by Type in 2024 & 2034
Figure 11. Global Gene Therapy in CNS Disorder Market Size by Type (2018-2034) & (US$ Million)
Figure 12. Global Gene Therapy in CNS Disorder Market Share by Type (2018-2034)
Figure 13. India Gene Therapy in CNS Disorder Market Share by Type in 2024 & 2034
Figure 14. India Gene Therapy in CNS Disorder Market Size by Type (2018-2034) & (US$ Million)
Figure 15. India Gene Therapy in CNS Disorder Market Share by Type (2018-2034)
Figure 16. Product Picture of Alzheimer's Disease
Figure 17. Product Picture of Huntington's Disease
Figure 18. Product Picture of Parkinson's Disease
Figure 19. Product Picture of Batten Disease
Figure 20. Global Gene Therapy in CNS Disorder Market Share by Application in 2024 & 2034
Figure 21. Global Gene Therapy in CNS Disorder Market Size by Application (2018-2034) & (US$ Million)
Figure 22. Global Gene Therapy in CNS Disorder Market Share by Application (2018-2034)
Figure 23. India Gene Therapy in CNS Disorder Market Share by Application in 2024 & 2034
Figure 24. India Gene Therapy in CNS Disorder Market Size by Application (2018-2034) & (US$ Million)
Figure 25. India Gene Therapy in CNS Disorder Market Share by Application (2018-2034)
Figure 26. The Top 5 and 10 Largest Companies of Gene Therapy in CNS Disorder in the World: Market Share by Gene Therapy in CNS Disorder Revenue in 2024
Figure 27. Global Gene Therapy in CNS Disorder Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 28. Global Gene Therapy in CNS Disorder Market Share by Region (2018-2034)
Figure 29. Americas Gene Therapy in CNS Disorder Market Size Growth Rate 2018-2034 (US$ Million)
Figure 30. Americas Gene Therapy in CNS Disorder Market Share by Type (2018-2034)
Figure 31. Americas Gene Therapy in CNS Disorder Market Share by Application (2018-2034)
Figure 32. United States Gene Therapy in CNS Disorder Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 33. Canada Gene Therapy in CNS Disorder Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 34. Mexico Gene Therapy in CNS Disorder Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 35. Brazil Gene Therapy in CNS Disorder Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 36. EMEA Gene Therapy in CNS Disorder Market Size Growth Rate 2018-2034 (US$ Million)
Figure 37. EMEA Gene Therapy in CNS Disorder Market Share by Type (2018-2034)
Figure 38. EMEA Gene Therapy in CNS Disorder Market Share by Application (2018-2034)
Figure 39. Europe Gene Therapy in CNS Disorder Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 40. Middle East Gene Therapy in CNS Disorder Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 41. Africa Gene Therapy in CNS Disorder Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 42. China Gene Therapy in CNS Disorder Market Size Growth Rate 2018-2034 (US$ Million)
Figure 43. China Gene Therapy in CNS Disorder Market Share by Type (2018-2034)
Figure 44. China Gene Therapy in CNS Disorder Market Share by Application (2018-2034)
Figure 45. APAC Gene Therapy in CNS Disorder Market Size Growth Rate 2018-2034 (US$ Million)
Figure 46. APAC Gene Therapy in CNS Disorder Market Share by Type (2018-2034)
Figure 47. APAC Gene Therapy in CNS Disorder Market Share by Application (2018-2034)
Figure 48. Japan Gene Therapy in CNS Disorder Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 49. South Korea Gene Therapy in CNS Disorder Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 50. China Taiwan Gene Therapy in CNS Disorder Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 51. Southeast Asia Gene Therapy in CNS Disorder Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 52. India Gene Therapy in CNS Disorder Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 53. Voyager Therapeutics Revenue Growth Rate in Gene Therapy in CNS Disorder Business (2018-2023)
Figure 54. Spark Therapeutics Revenue Growth Rate in Gene Therapy in CNS Disorder Business (2018-2023)
Figure 55. Novartis AG Revenue Growth Rate in Gene Therapy in CNS Disorder Business (2018-2023)
Figure 56. Bluebird Bio Inc. Revenue Growth Rate in Gene Therapy in CNS Disorder Business (2018-2023)
Figure 57. Biogen Revenue Growth Rate in Gene Therapy in CNS Disorder Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed